A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study
Gynecologic Oncology（2010）
摘要
Conclusion Mifepristone has not proven to be an effective agent in the treatment of patients with recurrent or persistent ovarian, peritoneal and fallopian tube cancers.
更多查看译文
关键词
Mifepristone,GOG,Epithelial ovarian cancer,Fallopian cancer,Primary peritoneal cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要